ArticleJAMA network open2023

Cardiovascular Outcomes of α-Blockers vs 5-α Reductase Inhibitors for Benign Prostatic Hyperplasia.

Jiandong Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.